Lv11
30 积分 2020-12-23 加入
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
5小时前
待确认
Novel TLE4‐NTRK2 fusion in a ganglioglioma identified by array‐CGH and confirmed by NGS: Potential for a gene targeted therapy
1个月前
已完结
Expanding the Spectrum of NR4A3 Fusion–Positive Gynecologic Leiomyosarcomas
1个月前
已完结
Intimal Sarcoma
4个月前
已完结
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets
4个月前
已完结
Epithelioid and spindle cell rhabdomyosarcoma with EWSR1::TFCP2 fusion mimicking metastatic lung cancer: A case report and literature review
5个月前
已完结
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
6个月前
已完结
MYH9::LTK Fusion in a Pediatric Acral Soft Tissue Spindle Cell Neoplasm
6个月前
已完结
Durable response to amivantamab in treatment refractory NSCLC harboring EGFR and complex MET mutations: A case report
6个月前
已完结
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial
6个月前
已完结
皖公网安备34019202002308
